Literature DB >> 12824491

Structure and properties of recombinant human pyridoxine 5'-phosphate oxidase.

Faik N Musayev1, Martino L Di Salvo, Tzu-Ping Ko, Verne Schirch, Martin K Safo.   

Abstract

Pyridoxine 5'-phosphate oxidase catalyzes the terminal step in the synthesis of pyridoxal 5'-phosphate. The cDNA for the human enzyme has been cloned and expressed in Escherichia coli. The purified human enzyme is a homodimer that exhibits a low catalytic rate constant of approximately 0.2 sec(-1) and K(m) values in the low micromolar range for both pyridoxine 5'phosphate and pyridoxamine 5'-phosphate. Pyridoxal 5'-phosphate is an effective product inhibitor. The three-dimensional fold of the human enzyme is very similar to those of the E. coli and yeast enzymes. The human and E. coli enzymes share 39% sequence identity, but the binding sites for the tightly bound FMN and substrate are highly conserved. As observed with the E. coli enzyme, the human enzyme binds one molecule of pyridoxal 5'-phosphate tightly on each subunit.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12824491      PMCID: PMC2323923          DOI: 10.1110/ps.0356203

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  19 in total

1.  Distribution of B6 vitamers in Escherichia coli as determined by enzymatic assay.

Authors:  T F Fu; M di Salvo; V Schirch
Journal:  Anal Biochem       Date:  2001-11-15       Impact factor: 3.365

2.  Immunohistochemical studies of brain pyridoxine-5'-phosphate oxidase.

Authors:  Jae Hoon Bahn; Oh Shin Kwon; Hye Mee Joo; Sang Ho Jang; Jinseu Park; In Koo Hwang; Tae Cheon Kang; Moo Ho Won; Hyeok Yil Kwon; Francis Kwok; Hyong Bai Kim; Sung Woo Cho; Soo Young Choi
Journal:  Brain Res       Date:  2002-01-25       Impact factor: 3.252

3.  Rabbit liver pyridoxamine (pyridoxine) 5'-phosphate oxidase. Purification and properties.

Authors:  M N Kazarinoff; D B McCormick
Journal:  J Biol Chem       Date:  1975-05-10       Impact factor: 5.157

4.  Crystallography & NMR system: A new software suite for macromolecular structure determination.

Authors:  A T Brünger; P D Adams; G M Clore; W L DeLano; P Gros; R W Grosse-Kunstleve; J S Jiang; J Kuszewski; M Nilges; N S Pannu; R J Read; L M Rice; T Simonson; G L Warren
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1998-09-01

5.  Aminopeptidase from Streptomyces griseus: primary structure and comparison with other zinc-containing aminopeptidases.

Authors:  B Maras; H M Greenblatt; G Shoham; A Spungin-Bialik; S Blumberg; D Barra
Journal:  Eur J Biochem       Date:  1996-03-15

6.  X-ray structure of Escherichia coli pyridoxine 5'-phosphate oxidase complexed with FMN at 1.8 A resolution.

Authors:  M K Safo; I Mathews; F N Musayev; M L di Salvo; D J Thiel; D J Abraham; V Schirch
Journal:  Structure       Date:  2000-07-15       Impact factor: 5.006

7.  ALSCRIPT: a tool to format multiple sequence alignments.

Authors:  G J Barton
Journal:  Protein Eng       Date:  1993-01

8.  X-ray structure of Escherichia coli pyridoxine 5'-phosphate oxidase complexed with pyridoxal 5'-phosphate at 2.0 A resolution.

Authors:  M K Safo; F N Musayev; M L di Salvo; V Schirch
Journal:  J Mol Biol       Date:  2001-07-20       Impact factor: 5.469

9.  Expression, purification, and characterization of recombinant Escherichia coli pyridoxine 5'-phosphate oxidase.

Authors:  M Di Salvo; E Yang; G Zhao; M E Winkler; V Schirch
Journal:  Protein Expr Purif       Date:  1998-08       Impact factor: 1.650

10.  Kinetic limitation and cellular amount of pyridoxine (pyridoxamine) 5'-phosphate oxidase of Escherichia coli K-12.

Authors:  G Zhao; M E Winkler
Journal:  J Bacteriol       Date:  1995-02       Impact factor: 3.490

View more
  34 in total

1.  Crystal structure of the novel PaiB transcriptional regulator from Geobacillus stearothermophilus.

Authors:  E V Filippova; J S Brunzelle; M E Cuff; H Li; A Joachimiak; W F Anderson
Journal:  Proteins       Date:  2011-06-01

2.  Molecular insights into the binding of coenzyme F420 to the conserved protein Rv1155 from Mycobacterium tuberculosis.

Authors:  Ellene H Mashalidis; Apostolos G Gittis; Aurelie Tomczak; Chris Abell; Clifton E Barry; David N Garboczi
Journal:  Protein Sci       Date:  2015-03-10       Impact factor: 6.725

3.  Molecular basis of reduced pyridoxine 5'-phosphate oxidase catalytic activity in neonatal epileptic encephalopathy disorder.

Authors:  Faik N Musayev; Martino L Di Salvo; Mario A Saavedra; Roberto Contestabile; Mohini S Ghatge; Alexina Haynes; Verne Schirch; Martin K Safo
Journal:  J Biol Chem       Date:  2009-09-15       Impact factor: 5.157

4.  Allosteric feedback inhibition of pyridoxine 5'-phosphate oxidase from Escherichia coli.

Authors:  Anna Barile; Angela Tramonti; Martino Luigi di Salvo; Isabel Nogués; Caterina Nardella; Francesco Malatesta; Roberto Contestabile
Journal:  J Biol Chem       Date:  2019-09-04       Impact factor: 5.157

5.  Global profiling of lysine reactivity and ligandability in the human proteome.

Authors:  Stephan M Hacker; Keriann M Backus; Michael R Lazear; Stefano Forli; Bruno E Correia; Benjamin F Cravatt
Journal:  Nat Chem       Date:  2017-07-31       Impact factor: 24.427

6.  The molecular structure of Rv2074, a probable pyridoxine 5'-phosphate oxidase from Mycobacterium tuberculosis, at 1.6 angstroms resolution.

Authors:  Bichitra K Biswal; Karolyn Au; Maia M Cherney; Craig Garen; Michael N G James
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2006-07-24

7.  Normal Cerebrospinal Fluid Pyridoxal 5'-Phosphate Level in a PNPO-Deficient Patient with Neonatal-Onset Epileptic Encephalopathy.

Authors:  Alina Levtova; Stephane Camuzeaux; Anne-Marie Laberge; Pierre Allard; Catherine Brunel-Guitton; Paola Diadori; Elsa Rossignol; Keith Hyland; Peter T Clayton; Philippa B Mills; Grant A Mitchell
Journal:  JIMD Rep       Date:  2015-03-12

8.  Pyridoxine responsiveness in novel mutations of the PNPO gene.

Authors:  Barbara Plecko; Karl Paul; Philippa Mills; Peter Clayton; Eduard Paschke; Oliver Maier; Oswald Hasselmann; Gudrun Schmiedel; Simone Kanz; Mary Connolly; Nicole Wolf; Eduard Struys; Sylvia Stockler; Lucia Abela; Doris Hofer
Journal:  Neurology       Date:  2014-03-21       Impact factor: 9.910

9.  Rv2074 is a novel F420 H2 -dependent biliverdin reductase in Mycobacterium tuberculosis.

Authors:  F Hafna Ahmed; A Elaaf Mohamed; Paul D Carr; Brendon M Lee; Karmen Condic-Jurkic; Megan L O'Mara; Colin J Jackson
Journal:  Protein Sci       Date:  2016-07-17       Impact factor: 6.725

Review 10.  Physiology, Biochemistry, and Applications of F420- and Fo-Dependent Redox Reactions.

Authors:  Chris Greening; F Hafna Ahmed; A Elaaf Mohamed; Brendon M Lee; Gunjan Pandey; Andrew C Warden; Colin Scott; John G Oakeshott; Matthew C Taylor; Colin J Jackson
Journal:  Microbiol Mol Biol Rev       Date:  2016-04-27       Impact factor: 11.056

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.